SysmexSSMXF +5.89%69 Days Payable is 42.40 as of Mar. 2026, which is 43% below its 10-year median of 74.21. GuruFocus rates SSMXF with a GF Score™ of 69/100 and a GF Value™ of $17.55 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Sysmex ranks worse than 70.1% on this metric.
Sysmex's average Accounts Payable for the
three
months ended in Mar. 2026 was $207 Mil. Sysmex's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $446 Mil.
Hence, Sysmex's Days Payable for the
three
months ended in Mar. 2026 was 42.40.
The historical rank and industry rank for Sysmex's Days Payable or its related term are showing as below:
SSMXF'
s Days Payable Range Over the Past 10 Years
Min: 45.93 Med: 74.21 Max: 86.42
Current: 45.93
During the past 13 years, Sysmex's highest Days Payable was 86.42. The lowest was 45.93. And the median was 74.21.
SSMXF's Days Payable is ranked worse than 70.1% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs SSMXF: 45.93
Sysmex's Days Payable
increased
from Mar. 2025 (41.14) to Mar. 2026 (42.40).
It may suggest that Sysmexdelayed paying its suppliers.
Sysmex Days Payable Related Terms
Sysmex Days Payable Historical Data
* Premium members only.
The historical data trend for Sysmex's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sysmex's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sysmex Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Days Payable distribution charts can be found below:
* The bar in red indicates where Sysmex's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sysmex's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sysmex (SSMXF) has a Days Payable of 42.40 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sysmex and its competitors. This is 43% below median its historical median of 74.21. Over the past decade, Sysmex's Days Payable has ranged from 45.93 to 86.42. According to the industry distribution chart, Sysmex ranks #558 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 70.1%.
Is Sysmex's Days Payable too high?
Sysmex's current Days Payable of 42.40 is 43% below median its 10-year median of 74.21. Over the past 10 years, this metric has ranged from a low of 45.93 to a high of 86.42. The Medical Devices & Instruments industry median Days Payable is 68.14. Sysmex's value of 42.40 is 37.8% below this industry median. Based on the distribution chart, Sysmex ranks #558 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sysmex has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sysmex's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sysmex ranks #558 out of 796 companies for Days Payable. This places Sysmex in the lower half of its industry. The industry median Days Payable is 68.14. Sysmex's value of 42.40 is 37.8% below this benchmark. Historically, Sysmex's own Days Payable has ranged from 45.93 to 86.42 over the past decade. While the company's 10-year median is 74.21 vs. the industry median of 68.14, Sysmex has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sysmex's current Days Payable of 42.40 is 37.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sysmex and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sysmex's current Days Payable is 42.40, which is 43% below median its own 10-year median of 74.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sysmex stock overvalued right now?
Based on GuruFocus' analysis, Sysmex (SSMXF) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.55, compared to a current price of $8.85 — trading 49.6% below its estimated fair value. The current Days Payable is 42.40, which is 43% below median its 10-year median of 74.21 and 37.8% below the Medical Devices & Instruments industry median of 68.14. Sysmex's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sysmex (SSMXF), the current Days Payable is 42.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sysmex (SSMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Sysmex stock appears to be undervalued.
The current stock price of $8.85 is trading 49.6% below its estimated GF Value™ of $17.55.
GuruFocus considers Sysmex to be Significantly Undervalued.
Key valuation signals for SSMXF:
Days Payable: 42.40 (43% below median its 10-year median of 74.21)
GF Value™: $17.55 vs. price of $8.85 (49.6% below fair value)
Industry Position: 37.8% below the Medical Devices & Instruments median (#558 of 796)
No single metric tells the full story. See the SSMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sysmex Corp manufactures and sells laboratory testing equipment and reagents. It conducts product development, manufacturing, sales, and service activities in domestic markets, while certain products are also developed, manufactured, and sold through its subsidiaries. The company operates through five reportable segments based on headquarters: Head Office Management, Americas Headquarters, EMEA Headquarters, China Headquarters, and AP Headquarters.
69GF Score
Get the complete analysis for SSMXF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSMXF has been successfully added to your 
